MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells

Abstract

BackgroundTwo mature miRNA species may be generated from the 5’ and 3’ arms of a pre-miRNA precursor. In most cases, only one species remains while the complementary species is degraded. However, co-existence of miRNA-5p and -3p species is increasingly being reported. In this work, we aimed to systematically investigate co-expression of miRNA-5p/3p in colon cancer cells in a genome-wide analysis, and to examine cross-targeting of the dysregulated miRNAs and 5p/3p species.ResultsFour colon cancer cell lines were examined relative to two normal colon tissues. Of the 1,190 miRNAs analyzed, 92 and 36 were found to be up- or down-regulated, respectively, in cancer cells. Nineteen co-expressed miRNA-5p/3p pairs were further identified suggesting frequent 5p/3p co-accumulation in colon cancer cells. Of these, 14 pairs were co-up-regulated and 3 pairs were co-down-regulated indicating concerted 5p/3p dysregulation. Nine dysregulated miRNA pairs fell into three miRNA gene families, namely let-7, mir-8/200 and mir-17, which showed frequent cross-targeting in the metastasis process. Focusing on the let-7d-5p/3p pair, the respectively targeted IGF1R and KRAS were shown to be in a reverse relationship with expression of the respective miRNA, which was confirmed in transient transfection assays using let-7d mimic or inhibitor. Targeting of KRAS by let-7d was previous reported; targeting of IGF1R by let-7d-5p was confirmed in luciferase assays in this study. The findings of let-7d-5p/3p and multiple other miRNAs targeting IGF1R, KRAS and other metastasis-related factors suggest that 5p/3p miRNAs contribute to cross-targeting of multiple cancer-associated factors and processes possibly to evade functional abolishment when any one of the crucial factors are inactivated.ConclusionsmiRNA-5p/3p species are frequently co-expressed and are coordinately regulated in colon cancer cells. In cancer cells, multiple cross-targeting by the miRNAs, including the co-existing 5p/3p species, frequently occurs in an apparent safe-proof scheme of miRNA regulation of important tumorigenesis processes. Further systematic analysis of co-existing miRNA-5p/3p pairs in clinical tissues is important in elucidating 5p/3p contributions to cancer pathogenesis.Electronic supplementary materialThe online version of this article (doi:10.1186/s12929-014-0095-x) contains supplementary material, which is available to authorized users.

Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data

“…Interestingly, mir-1307 was differentially expressed under MYCN knockdown, but showed reversed regulation in the 5p/3p species. Although the reverse direction of 5p/3p coexpression has been reported in several studies [56, 57], the mechanism and biological significance of preferred arm selection remains unknown.…”

Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma

“…It has been hypothesized that the main (-3p) and the passenger (-5p) strands might influence the expression of different targets and, in some cases, they can regulate invasiveness of cancer cells. 28 Concerning miR-149-5p, several lines of evidence suggest that in some cancer types other than melanoma, it may function as a tumor suppressor. For example, miR-149-5p expression was decreased in gastric cancer cell lines and in clinical specimens compared with normal counterparts.…”

Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K/Akt, WNT/β-catenin signal pathways

“…It functions through enhancing the protein synthesis required for cell proliferation [17]. Nowadays, with more and more researches about IGF1R, many other regulatory factors has been presented, such as let-7d-5p, miR-493, miR-497 and tumor suppressor p53, klotho [18][19][20][21][22]. Inflammation is known as a hallmark of cancer wherein diverse immune cells exert either pro-or anti-tumor properties and affect therapeutic resistance [23].…”